Sample size for a pilot study to estimate the CVintra [Power / Sample Size]

posted by yjlee168 Homepage – Kaohsiung, Taiwan, 2010-03-29 15:27 (5928 d 23:19 ago) – Posting: # 4979
Views: 16,213

Dear Helmut and Elmaestro,

❝ You are right with the sequential designs. If I don't have a lot (!) of previous data, I made them already my new standard.


So, it sounds like that the sequential designs (Method C or D suggested by Potvin D, et al., 2008) have been widely acceptable for regulatory agents (FDA/EMA/Japan/etc.). However, I don't quite remember that there is any regulation mentioned the sequential designs for ABE study. Am I wrong about this? Thanks.

All the best,
-- Yung-jin Lee
bear v2.9.6:- created by Hsin-ya Lee & Yung-jin Lee
Kaohsiung, Taiwan https://www.pkpd168.com/bear
Download link (updated) -> here

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
130 visitors (0 registered, 130 guests [including 22 identified bots]).
Forum time: 14:47 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5